550 million
people in the accessible population base

Saltlick estimates an individual's probability of developing cancer before symptoms appear, turning predictive insight into earlier, personalized prevention and diagnostic follow-up.

Saltlick Healthcare Pvt Ltd is an independent healthcare company building a preventive cancer-risk ecosystem for population-scale use. Its model combines AI-enabled risk assessment, clinical pathways, and connected care infrastructure to move cancer care upstream, shifting from Detect & Treat to Assess & Prevent.
550 million
people in the accessible population base
30,000+
Primary Health Centres and district hospitals



national public-health programme and policy alignment
Saltlick Healthcare Pvt Ltd is an independent company shaped by the scientific vision and entrepreneurial leadership of Dr. Raktim Chattopadhyay, PhD, a distinguished scientist, healthcare entrepreneur, and thought leader in oncology and medical nutrition.
Over two decades spent bridging research, translational science, and clinical practice, Dr. Chattopadhyay has built a body of work centered on reshaping how cancer risk, prevention, and care are approached at population scale. That grounding in cancer biology and nutrition science directly informs Saltlick's mission: moving India's cancer-care paradigm from reactive detection to systematic, preventive assessment.
Conventional cancer-care pathways often begin only after symptoms appear. By then, the opportunity for low-burden prevention, closer surveillance, and earlier diagnostic action may already be smaller.
Saltlick Healthcare Pvt Ltd is building a platform designed to act sooner: estimate an individual's probability of developing cancer before symptoms emerge, identify who needs closer attention, and guide each person toward an appropriate prevention or diagnostic pathway.
Saltlick Healthcare Pvt Ltd's approach pairs two things that, on their own, aren't enough: government reach and deployable technology.
Access to a population base of 550 million through 30,000+ Primary Health Centres and district hospitals, designed for alignment with public-health pathways including NHM, NPCDCS, and PM-JAY
Proprietary AI-driven cancer risk scoring, hub-and-spoke care infrastructure, and a digital referral backbone connecting screening to treatment
This PPP structure is designed to bring proactive risk assessment to people who currently fall outside conventional screening, making prevention and diagnostic follow-up more accessible, systematic, and timely.
Health Voitho works with Saltlick Healthcare Pvt Ltd as its technology partner, building the medical-technology ecosystem that enables the model end to end, from risk-assessment systems and clinical workflows to the connected infrastructure required across thousands of care sites.
This includes the technical and infrastructural foundation for:
The conditions that make this PPP model work in India, including rising lifestyle-driven cancer incidence, low screening penetration, and public health infrastructure that is present but under-leveraged, are not unique to India. They describe a broader set of geographies where a government-partnered, hub-and-spoke approach to cancer risk screening could be adapted rather than rebuilt from scratch.
Guided by WHO's projections on the rising cancer burden across low- and middle-income countries, the geographies that most closely mirror India's starting conditions include:
comparable demographic and infrastructure patterns to India
an established hub for medical value travel, well-positioned to anchor a regional screening and referral network
Visit Esperer Globalsignificant infrastructure gaps paired with rising lifestyle-cancer incidence
This is the long-term opportunity Saltlick's model and Health Voitho's technology platform are being built to support.
Saltlick Healthcare Pvt Ltd and Health Voitho are working toward a future in which cancer risk is understood before symptoms begin, allowing preventive action to start while it has the greatest chance to change the outcome.